ClinicalTrials.gov
ClinicalTrials.gov Menu

KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease : A 10-year Longitudinal Cohort Study of the Chronic Kidney Disease (KNOW-CKD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01630486
Recruitment Status : Active, not recruiting
First Posted : June 28, 2012
Last Update Posted : April 22, 2016
Sponsor:
Information provided by (Responsible Party):
Curie Ahn, Seoul National University Hospital

Brief Summary:

The goals of the KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease) study are 1) to establish a CKD cohort representing Korean CKD population for up to 10-year follow-up, and 2) to investigate the renal progression, mortality, complications, risk factors, role of biochemical parameters and the genetic influence.

KNOW-CKD Research Group comprises nephrologists, pediatric nephrologists, epidemiologists and statisticians from eleven centers in Korea. KNOW-CKD will enroll 2,850 individuals with CKD stage from 1 to 5 between 2011 and 2015 and follow them up to 10 years. Dialyzed patients or those with allograft kidney are excluded. At enrollment and at pre-specified intervals, laboratory tests will be conducted on the kidney function, biochemical profiles, anemia, cardiovascular complication (echocardiography, coronary CT, arterial stiffness), and mineral bone disorder. A biobank is also established for the DNA, serum and urine at regular interval. Information on the medical history, health questionnaires, QoL will also be collected. Web-based case-report forms (CRF) is developed for the systemic management of the patient data.


Condition or disease
Chronic Kidney Disease

Study Type : Observational
Actual Enrollment : 2450 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease
Study Start Date : March 2011
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Diseases
U.S. FDA Resources

Group/Cohort
glomerulonephritis
adult CKD patients, whose underlying etiology is glomerulonephritis, either clinically diagnosed or pathologically proven
hypertensive nephropathy
adult CKD patients, whose underlying etiology is hypertensive nephropathy
polycystic kidney disease
adult CKD patients, whose underlying etiology is autosomal dominant polycystic kidney disease
diabetic nephropathy
adult CKD patients, whose underlying etiology is diabetic nephropathy



Primary Outcome Measures :
  1. overall mortality [ Time Frame: 10 years ]

Secondary Outcome Measures :
  1. cardiovascular event [ Time Frame: 10 years ]
  2. renal replacement therapy [ Time Frame: 10 years ]
    dialysis or kidney transplantation

  3. doubling of serum creatinine [ Time Frame: 10 years ]

Biospecimen Retention:   Samples With DNA
A biobank is also established for the DNA, serum and urine taken at regular interval.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
CKD stage 1 through 5 Ages below 75
Criteria

Inclusion Criteria:

  • Age: >20 and <75 yr,
  • CKD stage 1 through 5
  • predialysis

Exclusion Criteria:

  • Unable or unwilling to give consent
  • Previously received chronic dialysis
  • Previous any organ transplant
  • Heart failure
  • Known liver cirrhosis
  • past or current cancer
  • Pregnant women
  • Single kidney due to trauma or donation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01630486


Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Curie Ahn, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01630486     History of Changes
Other Study ID Numbers: KNOW-CKD
First Posted: June 28, 2012    Key Record Dates
Last Update Posted: April 22, 2016
Last Verified: April 2016

Keywords provided by Curie Ahn, Seoul National University Hospital:
renal progression
mortality
complications
risk factors
role of biochemical parameters
genetic influence

Additional relevant MeSH terms:
Kidney Diseases
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency